While Bausch Health Companies Inc has underperformed by -1.96%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BHC fell by -13.28%, with highs and lows ranging from $8.69 to $4.25, whereas the simple moving average jumped by 12.18% in the last 200 days.
On December 09, 2025, Barclays started tracking Bausch Health Companies Inc (NYSE: BHC) recommending Equal Weight. A report published by Piper Sandler on August 02, 2024, Downgraded its rating to ‘Underweight’ for BHC. Raymond James also rated BHC shares as ‘Mkt Perform’, setting a target price of $8 on the company’s shares in an initiating report dated July 10, 2024. Jefferies September 20, 2023d the rating to Buy on September 20, 2023, and set its price target from $9 to $16. TD Cowen June 16, 2023d its ‘Outperform’ rating to ‘Market Perform’ for BHC, as published in its report on June 16, 2023. RBC Capital Mkts also rated the stock as ‘Sector Perform’.
Analysis of Bausch Health Companies Inc (BHC)
Further, the quarter-over-quarter increase in sales is 6.81%, showing a positive trend in the upcoming months.
Bausch Health Companies Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. Taking into account the quick ratio of the company, currently set at 0.97, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and BHC has an average volume of 2.45M. Furthermore, long-term investors anticipate a median target price of $7.29, showing growth from the present price of $6.99, which can serve as yet another indication of whether BHC is worth investing in or should be passed over.
How Do You Analyze Bausch Health Companies Inc Shares?
Drug Manufacturers – Specialty & Generic giant Bausch Health Companies Inc (BHC) is based in the Canada and is one of the largest companies in the market. When comparing Bausch Health Companies Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 7.21, there is a growth in quarterly earnings of 306.63%.
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 11.44%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 66.58% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
